Independent report

Mpox vaccination programme, JCVI advice: 10 November

Statement setting out the advice from JCVI on the use of the MVA-BN vaccination for the prevention of mpox.

• From: Department of Health and Social Care
• Published: 10 November 2023

Documents

JCVI statement on mpox vaccination as a routine programme

HTML

Details

This statement provides Joint Committee on Vaccination and Immunisation (JCVI) advice on the Modified Vaccinia Ankara - Bavarian Nordic (MVA-BN) vaccine for the prevention of mpox in terms of programme cost-effectiveness and likely impact on epidemiology.

Published 10 November 2023